291 related articles for article (PubMed ID: 30684592)
21. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
[TBL] [Abstract][Full Text] [Related]
22. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
23. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q; Han T; Sheng X; Zhang N; Wang P
Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
26. miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.
Chen X; Shi J; Zhong J; Huang Z; Luo X; Huang Y; Feng S; Shao J; Liu D
Int J Exp Pathol; 2015 Dec; 96(6):427-32. PubMed ID: 26852690
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Lechner M; Schartinger VH; Steele CD; Nei WL; Ooft ML; Schreiber LM; Pipinikas CP; Chung GT; Chan YY; Wu F; To KF; Tsang CM; Pearce W; Morelli D; Philpott M; Masterson L; Nibhani R; Wells G; Bell CG; Koller J; Delecluse S; Yip YL; Liu J; Forde CT; Forster MD; Jay A; Dudás J; Krapp A; Wan S; Uprimny C; Sprung S; Haybaeck J; Fenton TR; Chester K; Thirlwell C; Royle G; Marafioti T; Gupta R; Indrasari SR; Herdini C; Slim MAM; Indrawati I; Sutton L; Fles R; Tan B; Yeong J; Jain A; Han S; Wang H; Loke KSH; He W; Xu R; Jin H; Cheng Z; Howard D; Hwang PH; Le QT; Tay JK; West RB; Tsao SW; Meyer T; Riechelmann H; Oppermann U; Delecluse HJ; Willems SM; Chua MLK; Busson P; Lo KW; Wollmann G; Pillay N; Vanhaesebroeck B; Lund VJ
Nat Commun; 2021 Jan; 12(1):117. PubMed ID: 33402692
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma.
Gao W; Li ZH; Chen S; Chan JY; Yin M; Zhang MJ; Wong TS
Oncotarget; 2017 Mar; 8(12):20297-20308. PubMed ID: 28423621
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.
Ma L; Deng X; Wu M; Zhang G; Huang J
FEBS Lett; 2014 May; 588(9):1562-70. PubMed ID: 24613926
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.
He B; Li W; Wu Y; Wei F; Gong Z; Bo H; Wang Y; Li X; Xiang B; Guo C; Liao Q; Chen P; Zu X; Zhou M; Ma J; Li X; Li Y; Li G; Xiong W; Zeng Z
Cell Death Dis; 2016 Sep; 7(9):e2353. PubMed ID: 27584792
[TBL] [Abstract][Full Text] [Related]
31. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma.
Lei T; Yuen KS; Xu R; Tsao SW; Chen H; Li M; Kok KH; Jin DY
Int J Cancer; 2013 Jul; 133(1):79-87. PubMed ID: 23280823
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages.
Huang D; Song SJ; Wu ZZ; Wu W; Cui XY; Chen JN; Zeng MS; Su SC
Cancer Res; 2017 Jul; 77(13):3591-3604. PubMed ID: 28484077
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
35. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
36. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
37. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-κB.
Shi Z; Hu Z; Chen D; Huang J; Fan J; Zhou S; Wang X; Hu J; Huang F
Mol Med Rep; 2016 Feb; 13(2):1732-8. PubMed ID: 26718506
[TBL] [Abstract][Full Text] [Related]
39. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
[TBL] [Abstract][Full Text] [Related]
40. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
